Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H10O7 |
Molecular Weight | 302.2357 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC2=C(C=C1)C(=O)C(O)=C(O2)C3=CC(O)=C(O)C(O)=C3
InChI
InChIKey=SOEDEYVDCDYMMH-UHFFFAOYSA-N
InChI=1S/C15H10O7/c16-7-1-2-8-11(5-7)22-15(14(21)12(8)19)6-3-9(17)13(20)10(18)4-6/h1-5,16-18,20-21H
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2840 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3708757 |
|||
Target ID: CHEMBL2363065 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8117326 |
|||
Target ID: CHEMBL3004 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15670588 |
5.0 µM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3708757 |
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors. | 1996 Dec |
|
Free radical scavenging abilities of flavonoids as mechanism of protection against mutagenicity induced by tert-butyl hydroperoxide or cumene hydroperoxide in Salmonella typhimurium TA102. | 2003 Sep 9 |
|
Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. | 2004 Feb 4 |
|
Kinetic study of flavonoid reactions with stable radicals. | 2004 May 19 |
|
Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. | 2005 Feb 15 |
|
Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug-resistant colon cancer cells expressing MDR1/LRP. | 2005 Mar-Apr |
|
Antimicrobial activity of flavonoids. | 2005 Nov |
|
An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers. | 2006 Dec 1 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4655415
Examination of both urine extracts from robinetin-fed rats
(200mg/rat) and ether extracts ofrobinetin incubation
mixtures (10mg/tube) revealed the presence of large
amounts of unchanged robinetin.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15670588
Robinetin inhibited MRP2 activity more than 50% at
25 uM concentration.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID30197654
Created by
admin on Fri Dec 15 18:39:15 GMT 2023 , Edited by admin on Fri Dec 15 18:39:15 GMT 2023
|
PRIMARY | |||
|
KJ6DBC4U7E
Created by
admin on Fri Dec 15 18:39:15 GMT 2023 , Edited by admin on Fri Dec 15 18:39:15 GMT 2023
|
PRIMARY | |||
|
407331
Created by
admin on Fri Dec 15 18:39:15 GMT 2023 , Edited by admin on Fri Dec 15 18:39:15 GMT 2023
|
PRIMARY | |||
|
5281692
Created by
admin on Fri Dec 15 18:39:15 GMT 2023 , Edited by admin on Fri Dec 15 18:39:15 GMT 2023
|
PRIMARY | |||
|
207-709-6
Created by
admin on Fri Dec 15 18:39:15 GMT 2023 , Edited by admin on Fri Dec 15 18:39:15 GMT 2023
|
PRIMARY | |||
|
656274
Created by
admin on Fri Dec 15 18:39:15 GMT 2023 , Edited by admin on Fri Dec 15 18:39:15 GMT 2023
|
PRIMARY | |||
|
490-31-3
Created by
admin on Fri Dec 15 18:39:15 GMT 2023 , Edited by admin on Fri Dec 15 18:39:15 GMT 2023
|
PRIMARY | |||
|
8876
Created by
admin on Fri Dec 15 18:39:15 GMT 2023 , Edited by admin on Fri Dec 15 18:39:15 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD